The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical efficacy and biomarker analysis of pre-operative ipilimumab plus nivolumab in stage III urothelial cancer: The NABUCCO trial update.
 
Chantal Stockem
No Relationships to Disclose
 
Alberto Gil Jimenez
No Relationships to Disclose
 
Jeroen van Dorp
No Relationships to Disclose
 
Nick Van Dijk
Employment - Netherlands Cancer Insitute
 
Maurits L van Montfoort
No Relationships to Disclose
 
Maartje Alkemade
No Relationships to Disclose
 
Iris M. Seignette
No Relationships to Disclose
 
Annegien Broeks
No Relationships to Disclose
 
Erik Hooijberg
No Relationships to Disclose
 
Wim Brugman
No Relationships to Disclose
 
Laura Mertens
Consulting or Advisory Role - Janssen
Speakers' Bureau - Medtalks
 
Bas W.G. van Rhijn
Consulting or Advisory Role - Incyte International Biosciences (Inst); QED Therapeutics (Inst)
 
Jeantine M De Feijter
Consulting or Advisory Role - Janssen
 
Toine van der Heijden
Consulting or Advisory Role - Janssen; Merck
 
Niven Mehra
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Janssen-Cilag; MSD Oncology (Inst); Pfizer
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); AstraZeneca/Merck (Inst); Bristol Myers Squibb Foundation (Inst); Janssen-Cilag (Inst)
 
Richard P. Meijer
Employment - University Medical Center Utrecht
Consulting or Advisory Role - Bristol-Myers Squibb; Janssen; Merck; MSD
Speakers' Bureau - ISMAR Healthcare; Two Hands Events
Research Funding - Astellas Pharma (Inst); Janssen (Inst); Merck (Inst)
 
Britt Suelmann
No Relationships to Disclose
 
Daniel J Vis
Research Funding - Bristol-Myers Squibb (Inst)
Patents, Royalties, Other Intellectual Property - Mosaic Therapeutics (Inst)
 
Lodewyk F.A. Wessels
Research Funding - Bristol-Myers Squibb
Patents, Royalties, Other Intellectual Property - Mosaic Therapeutics
 
Michiel Simon Van Der Heijden
Stock and Other Ownership Interests - Gilead Sciences
Consulting or Advisory Role - Astellas Pharma (Inst); AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Janssen (Inst); MSD Oncology (Inst); Pfizer (Inst); Roche/Genentech (Inst); Seagen (Inst)
Research Funding - 4SC (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Roche (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; MSD Oncology; Novartis; Roche